Biodesix, Inc. BDSX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $25.57M+34.7% | $18.99M+14.4% | $16.6M-19.9% | $20.73M+17.8% | $17.6M-32.9% | ||
| $9.5M+5.1% | $9.04M-28.7% | $12.67M+70.1% | $7.45M-2.5% | $7.64M-11.2% | ||
| $5.84M+29.9% | $4.5M+9.0% | $4.12M-3.4% | $4.27M-2.6% | $4.38M-5.5% | ||
| $40.91M+25.8% | $32.52M-2.6% | $33.4M+2.9% | $32.45M+9.5% | $29.62M-25.0% | ||
| $24.19M-2.5% | $24.82M-2.5% | $25.46M-2.6% | $26.14M-3.1% | $26.97M-3.1% | ||
| $3.19M+6.4% | $3M+1.9% | $2.94M+39.7% | $2.11M+7.3% | $1.96M+11.0% | ||
| $15.03M0.0% | $15.03M0.0% | $15.03M0.0% | $15.03M0.0% | $15.03M0.0% | ||
| $3.45M-11.1% | $3.88M-11.2% | $4.38M-10.2% | $4.87M-9.1% | $5.36M-8.8% | ||
| $7.86M-4.5% | $8.23M+9.6% | $7.51M+5.0% | $7.15M-2.0% | $7.3M+0.6% | ||
| $53.73M-2.2% | $54.96M-0.7% | $55.32M0.0% | $55.3M-2.3% | $56.62M-2.0% | ||
| $94.64M+8.2% | $87.48M-1.4% | $88.72M+1.1% | $87.74M+1.7% | $86.24M-11.3% | ||
| $3.65M+18.5% | $3.08M-14.8% | $3.62M+21.7% | $2.97M+1.6% | $2.93M+33.3% | ||
| $927K-6.6% | $992K+55.7% | $637K-0.2% | $638K-41.4% | $1.09M+69.7% | ||
| $223K-76.8% | $961K-65.3% | $2.77M+349% | $617K-21.7% | $788K+16.2% | ||
| $1.45M+6.5% | $1.36M-2.2% | $1.39M+13.1% | $1.23M+12.6% | $1.09M+52.2% | ||
| $14.49M-16.9% | $17.44M-3.9% | $18.15M+19.7% | $15.16M+13.8% | $13.32M-7.0% | ||
| $46.49M-2.0% | $47.45M+0.7% | $47.11M+0.7% | $46.78M+27.5% | $36.69M+0.8% | ||
| $23.67M-1.5% | $24.04M-1.5% | $24.41M+1.2% | $24.11M-1.5% | $24.48M-1.4% | ||
| $25.12M-1.1% | $25.4M-1.6% | $25.81M+1.8% | $25.34M-0.9% | $25.57M+0.1% | ||
| $860K-15.8% | $1.02M+32.8% | $769K+40.1% | $549K-20.7% | $692K-15.1% | ||
| $71.02M-2.1% | $72.51M+0.3% | $72.29M+1.2% | $71.44M+15.5% | $61.87M-0.3% | ||
| $85.51M-4.9% | $89.94M-0.6% | $90.44M+4.4% | $86.6M+15.2% | $75.18M-1.6% | ||
| $10K+25.0% | $8K0.0% | $8K-94.5% | $146K0.0% | $146K+1,986% | ||
| $514.68M+3.9% | $495.29M+0.7% | $492.05M+1.2% | $486.06M+0.3% | $484.51M+0.2% | ||
| -$505.56M-1.6% | -$497.76M-0.8% | -$493.78M-1.8% | -$485.07M-2.4% | -$473.6M-2.4% | ||
| $9.13M+470% | -$2.47M-43.1% | -$1.72M-251% | $1.14M-89.7% | $11.06M-47.0% | ||
| $94.64M+8.2% | $87.48M-1.4% | $88.72M+1.1% | $87.74M+1.7% | $86.24M-11.3% | ||
| $5.84M+29.9% | $4.5M+9.0% | $4.12M-3.4% | $4.27M-2.6% | $4.38M-5.5% | ||
| $7.86M-4.5% | $8.23M+9.6% | $7.51M+5.0% | $7.15M-2.0% | $7.3M+0.6% | ||
| $3.19M+6.4% | $3M+1.9% | $2.94M+39.7% | $2.11M+7.3% | $1.96M+11.0% | ||
| $3.45M-11.1% | $3.88M-11.2% | $4.38M-10.2% | $4.87M-9.1% | $5.36M-8.8% | ||
| $3.19M+6.4% | $3M+1.9% | $2.94M+39.7% | $2.11M+7.3% | $1.96M+11.0% | ||
| $7.86M-4.5% | $8.23M+9.6% | $7.51M+5.0% | $7.15M-2.0% | $7.3M+0.6% | ||
| $3.19M+6.4% | $3M+1.9% | $2.94M+39.7% | $2.11M+7.3% | $1.96M+11.0% | ||
| $7.86M-4.5% | $8.23M+9.6% | $7.51M+5.0% | $7.15M-2.0% | $7.3M+0.6% | ||
| $8.23M-25.4% | $11.03M+13.5% | $9.72M+0.4% | $9.68M+30.8% | $7.4M-26.4% | ||
| $8.23M-25.4% | $11.03M+13.5% | $9.72M+0.4% | $9.68M+30.8% | $7.4M-26.4% | ||
| $927K-6.6% | $992K+55.7% | $637K-0.2% | $638K-41.4% | $1.09M+69.7% | ||
| —— | —— | —— | —— | —— | ||
| $71.61M-1.7% | $72.85M-0.1% | $72.92M+1.1% | $72.13M+15.8% | $62.27M+0.5% | ||
| $10K+25.0% | $8K0.0% | $8K-94.5% | $146K0.0% | $146K+1,986% | ||
| $46.49M-2.0% | $47.45M+0.7% | $47.11M+0.7% | $46.78M+27.5% | $36.69M+0.8% | ||
| $2K-66.7% | $6K-45.5% | $11K-31.3% | $16K-11.1% | $18K-14.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Biodesix, Inc.'s total assets?
- Biodesix, Inc. (BDSX) holds $94.6M in total assets, up 9.7% year over year.
- How much debt does Biodesix, Inc. have?
- Biodesix, Inc. carries $71.6M in total debt against $9.1M of shareholders' equity, a debt-to-equity ratio of 7.84.
- How much cash does Biodesix, Inc. have?
- Biodesix, Inc. holds $25.6M in cash and equivalents.
- Can Biodesix, Inc. cover its short-term obligations?
- Its current ratio is 2.82 — current assets exceed current liabilities.
- Where does Biodesix, Inc.'s balance sheet data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
